ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,231, issued on April 7, was assigned to Kanna Health Ltd (Kent, Great Britain).
"Crystalline salt forms of mesembrine" was invented by Ryan Joseph Protzko (Marriottsville, Md.) and Royston Anthony Gray (Essex, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel crystalline salt forms of mesembrine, also known as 3a-(3,4-dimethoxyphenyl)-octahydro-1-methy-6H-indol-6-one. Mesembrine has the chemical formula C17H23NO3. The invention further relates to the preparation of a novel crystalline salt of mesembrine and to the use of the mesembrine salt as a medicament. In one embodiment the novel crystalline sal...